HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takashi Yoshida Selected Research

oenothein B

5/2021Oenothein B, a Bioactive Ellagitannin, Activates the Extracellular Signal-Regulated Kinase 2 Signaling Pathway in the Mouse Brain.
5/2013Oenothein B suppresses lipopolysaccharide (LPS)-induced inflammation in the mouse brain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Takashi Yoshida Research Topics

Disease

49Neoplasms (Cancer)
04/2022 - 11/2002
23Breast Neoplasms (Breast Cancer)
09/2018 - 01/2003
13Carcinoma (Carcinomatosis)
11/2022 - 12/2017
13Infections
05/2021 - 08/2008
12Multiple Myeloma
02/2022 - 09/2003
11Neoplasm Metastasis (Metastasis)
11/2022 - 01/2003
9Lymphoma (Lymphomas)
04/2021 - 01/2011
6Pain (Aches)
02/2022 - 07/2011
6Urinary Bladder Neoplasms (Bladder Cancer)
03/2021 - 12/2015
6Inflammation (Inflammations)
01/2021 - 05/2013
5Renal Cell Carcinoma (Grawitz Tumor)
04/2022 - 04/2014
5Lymphatic Metastasis
05/2020 - 01/2003
5Hematologic Neoplasms (Hematological Malignancy)
06/2018 - 02/2004
5Carcinogenesis
09/2003 - 02/2002
4Leukemia
12/2018 - 09/2003
4Lower Urinary Tract Symptoms
08/2017 - 09/2015
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
01/2017 - 04/2015
4Graft vs Host Disease (Graft-Versus-Host Disease)
08/2015 - 05/2005
4Body Weight (Weight, Body)
04/2015 - 04/2002
4Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2014 - 06/2012
3Disease Progression
04/2022 - 08/2007
3Ischemic Stroke
09/2021 - 06/2020
3Urolithiasis
01/2021 - 01/2018
3Hemorrhage
10/2020 - 02/2008
3Fever (Fevers)
08/2019 - 01/2014
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2019 - 03/2012
3Pneumonia (Pneumonitis)
12/2018 - 01/2010
3Sepsis (Septicemia)
01/2018 - 01/2011
3Pleurisy (Pleuritis)
11/2016 - 01/2014
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
02/2013 - 01/2006
3B-Cell Lymphoma (Lymphoma, B Cell)
01/2013 - 01/2010
3Margins of Excision
03/2010 - 01/2006
2Hyperthermia
10/2022 - 01/2021
2Schizophrenia (Dementia Praecox)
01/2022 - 06/2012
2Spinal Cord Injuries (Spinal Cord Injury)
11/2021 - 01/2011

Drug/Important Bio-Agent (IBA)

8Estrogen ReceptorsIBA
08/2018 - 12/2003
6Proteins (Proteins, Gene)FDA Link
02/2022 - 11/2005
5Rituximab (Mabthera)FDA Link
02/2021 - 01/2010
5Dexamethasone (Maxidex)FDA LinkGeneric
04/2020 - 03/2016
5DNA (Deoxyribonucleic Acid)IBA
02/2020 - 09/2013
5Hormones (Hormone)IBA
06/2016 - 04/2002
5PolyphenolsIBA
05/2013 - 04/2002
4pembrolizumabIBA
01/2022 - 03/2020
4AcidsIBA
06/2021 - 02/2002
4Hemoglobins (Hemoglobin)IBA
02/2021 - 04/2002
4Tryptophan (L-Tryptophan)FDA Link
12/2020 - 06/2015
4SteroidsIBA
01/2019 - 11/2002
4Fluorouracil (Carac)FDA LinkGeneric
09/2018 - 06/2004
4Progesterone Receptors (Progesterone Receptor)IBA
06/2016 - 01/2007
3Immune Checkpoint InhibitorsIBA
11/2022 - 02/2021
3ThuliumIBA
05/2022 - 01/2018
3Protons (Proton)IBA
01/2021 - 12/2018
3Lenalidomide (CC 5013)FDA Link
04/2020 - 03/2016
3Triglycerides (Triacylglycerol)IBA
01/2020 - 04/2002
3Anti-Bacterial Agents (Antibiotics)IBA
01/2020 - 08/2009
3Cisplatin (Platino)FDA LinkGeneric
09/2018 - 02/2005
3Bortezomib (Velcade)FDA Link
02/2018 - 03/2016
3Paclitaxel (Taxol)FDA LinkGeneric
11/2016 - 06/2004
3Tacrolimus (Prograf)FDA LinkGeneric
08/2015 - 05/2005
3LipopolysaccharidesIBA
04/2015 - 05/2013
3TamoxifenFDA LinkGeneric
02/2014 - 02/2003
3Methotrexate (Mexate)FDA LinkGeneric
01/2013 - 06/2005
3Pharmaceutical PreparationsIBA
01/2013 - 03/2008
3TanninsIBA
12/2012 - 02/2003
3TeaIBA
02/2003 - 04/2002
2Biological ProductsIBA
10/2022 - 08/2016
2HolmiumIBA
05/2022 - 04/2022
2EverolimusFDA Link
04/2022 - 06/2016
2NivolumabIBA
04/2022 - 01/2018
2Biomarkers (Surrogate Marker)IBA
02/2022 - 02/2011
2Hematoxylin (Haematoxylon)IBA
01/2022 - 03/2021
2Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 03/2021
2Calcium Channels (Calcium Channel)IBA
01/2022 - 10/2012
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
01/2022 - 01/2016
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
2oenothein BIBA
05/2021 - 05/2013
2Phenobarbital (Luminal)FDA Link
03/2021 - 01/2013

Therapy/Procedure

35Therapeutics
11/2022 - 12/2003
18Drug Therapy (Chemotherapy)
02/2022 - 01/2003
8Radiotherapy
05/2019 - 02/2005
7Hematopoietic Stem Cell Transplantation
07/2019 - 10/2007
7Stem Cell Transplantation
11/2018 - 02/2004
7Lymph Node Excision (Lymph Node Dissection)
09/2018 - 09/2005
5Lasers (Laser)
05/2022 - 12/2018
4Immunotherapy
11/2022 - 10/2011
4Stents
01/2021 - 01/2019
4Bone Marrow Transplantation (Transplantation, Bone Marrow)
07/2019 - 02/2006
4Cystectomy
03/2017 - 12/2015
4Neoadjuvant Therapy
01/2016 - 01/2007
4Transplantation
08/2015 - 09/2003
4Segmental Mastectomy (Lumpectomy)
06/2013 - 07/2005
3Nephrectomy
04/2022 - 01/2016
3Laser Therapy (Surgery, Laser)
04/2022 - 01/2018
3Thrombectomy
09/2021 - 06/2020
3Mastectomy (Mammectomy)
09/2018 - 04/2011
3Catheters
01/2018 - 06/2015
3Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2012 - 01/2006
2Nephroureterectomy
07/2022 - 01/2020
2Palliative Care (Palliative Therapy)
02/2022 - 04/2012
2Oral Administration
06/2021 - 01/2004